CIMAvax EGF vaccine for stage IIIb/IV non-small cell lung carcinoma

被引：6
作者：
Cheng, Jian Y. [1 ,2 ]
Kananathan, Ratnavelu [1 ,2 ]
机构：
[1] Monash Univ, Cent Med Sch, Clayton, Vic, Australia
[2] NCI Hosp, Nilai, Negeri Sembilan, Malaysia
来源：
HUMAN VACCINES & IMMUNOTHERAPEUTICS | 2012年 / 8卷 / 12期
关键词：
lung; cimavax; epidermal growth factor (EGF); non small cell lung cancer (NSCLC); CANCER VACCINE; HUMAN VOLUNTEERS; CLINICAL-TRIAL; IMMUNOGENICITY; CHEMOTHERAPY; DIAGNOSIS; SURVIVAL; THERAPY; PROTEIN;
D O I：
10.4161/hv.21744
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
This case report documents the use of the CIMAvax Epidermal Growth Factor vaccine regimen in a 54 y old female with stage IIIb non-small cell lung carcinoma. Even after 48 mo since diagnosis her ECOG performance remains at zero. Further, this report documents a reaction to the vaccine of grade 3 severity not previously documented.
引用
收藏
页码：1799 / 1801
页数：3
相关论文
共 22 条
[1]  
[Anonymous], 2009, COMM TERM CRIT ADV E
[2]   Allergy - 2. Anaphylaxis: diagnosis and management [J].
Brown, Simon G. A. ;
Mullins, Raymond J. ;
Gold, Michael S. .
MEDICAL JOURNAL OF AUSTRALIA, 2006, 185 (05) :283-289
[3]   Adjuvants for Enhancing the Immunogenicity of Whole Tumor Cell Vaccines [J].
Chiang, Cheryl Lai-Lai ;
Kandalaft, Lana E. ;
Coukos, George .
INTERNATIONAL REVIEWS OF IMMUNOLOGY, 2011, 30 (2-3) :150-182
[4]   Non-small-cell lung cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-up [J].
D'Addario, G. ;
Felip, E. .
ANNALS OF ONCOLOGY, 2008, 19 :39-40
[5]   Effective inhibition of the epidermal growth factor/epidermal growth factor receptor binding by anti-epidermal growth factor antibodies is related to better survival in advanced non-small-cell lung cancer patients treated with the epidermal growth factor cancer vaccine [J].
Garcia, Beatriz ;
Neninger, Elia ;
de la Torre, Ana ;
Leonard, Idrissa ;
Martinez, Rocio ;
Viada, Carmen ;
Gonzalez, Gisela ;
Mazorra, Zaima ;
Lage, Agustin ;
Crombet, Tania .
CLINICAL CANCER RESEARCH, 2008, 14 (03) :840-846
[6]   Cancer vaccines for hormone/growth factor immune deprivation:: A feasible approach for cancer treatment [J].
Gonzalez, G. ;
Lage, A. .
CURRENT CANCER DRUG TARGETS, 2007, 7 (03) :229-241
[7]  
Gonzalez G., 2002, Autoimmunity Reviews, V1, P89, DOI 10.1016/S1568-9972(01)00015-5
[8]   Epidermal growth factor-based cancer vaccine for non-small-cell lung cancer therapy [J].
Gonzalez, G ;
Crombet, T ;
Torres, F ;
Catala, M ;
Alfonso, L ;
Osorio, M ;
Neninger, E ;
Garcia, B ;
Mulet, A ;
Perez, R ;
Lage, R .
ANNALS OF ONCOLOGY, 2003, 14 (03) :461-466
[9]   A novel cancer vaccine composed of human-recombinant epidermal growth factor linked to a carrier protein: Report of a pilot clinical trial [J].
Gonzalez, G ;
Crombet, T ;
Catala, M ;
Mirabal, V ;
Hernandez, JC ;
Gonzalez, Y ;
Marinello, P ;
Guillen, G ;
Lage, A .
ANNALS OF ONCOLOGY, 1998, 9 (04) :431-435
[10]   Therapeutic vaccination with Epidermal Growth Factor (EGF) in advanced lung cancer -: Analysis of pooled data from three clinical trials [J].
Gonzalez, Gisela ;
Crombet, Tania ;
Neninger, Elia ;
Viada, Carmen ;
Lage, Agustin .
HUMAN VACCINES, 2007, 3 (01) :8-13
123